Medios AG/€ILM1
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Medios AG
Medios AG, established in 2016 and headquartered in Berlin, Germany, operates in the specialty pharmaceutical sector, focusing on the supply and production of individualized medications. The company operates through two primary segments: Pharmaceutical Supply, offering products for oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia; and Patient-Specific Therapies, manufacturing customized medications such as cytostatic infusions, antibody therapies, and parenteral nutrition solutions for pharmacies. With nine locations across Germany, Medios maintains a robust regional supply network. In 2023, the company reported revenues of €1.8 billion, reflecting a 10.8% increase from the previous year. ([uk.marketscreener.com](https://uk.marketscreener.com/quote/stock/MEDIOS-AG-32018909/news/Medios-Fact-Sheet-November-2024-48379781/?utm_source=openai))
Ticker
€ILM1
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
1,037
ISIN
DE000A1MMCC8
Website
Medios AG Metrics
BasicAdvanced
€317M
20.97
€0.59
1.20
-
Price and volume
Market cap
€317M
Beta
1.2
52-week high
€12.48
52-week low
€11.12
Financial strength
Current ratio
1.956
Quick ratio
1.375
Long term debt to equity
36.898
Total debt to equity
42.876
Interest coverage (TTM)
2.89%
Profitability
EBITDA (TTM)
69.685
Gross margin (TTM)
8.97%
Net profit margin (TTM)
0.78%
Operating margin (TTM)
2.01%
Effective tax rate (TTM)
41.07%
Revenue per employee (TTM)
€1,840,000
Management effectiveness
Return on assets (TTM)
3.09%
Return on equity (TTM)
3.02%
Valuation
Price to earnings (TTM)
20.972
Price to revenue (TTM)
0.164
Price to book
0.61
Price to tangible book (TTM)
23.14
Price to free cash flow (TTM)
11.712
Free cash flow yield (TTM)
8.54%
Free cash flow per share (TTM)
105.79%
Growth
Revenue change (TTM)
5.62%
Earnings per share change (TTM)
-22.28%
3-year revenue growth (CAGR)
10.01%
3-year earnings per share growth (CAGR)
9.44%
Bulls say / Bears say
Medios AG reported a record quarter in Q3 2024, with significant increases in earnings and margins, indicating strong operational performance. (menafn.com)
Analysts forecast Medios AG's earnings to grow by 34.03% per year, suggesting robust future profitability. (simplywall.st)
Medios AG is trading at 59.6% below its estimated fair value, indicating potential for significant stock appreciation. (simplywall.st)
Medios AG's net income decreased by 43.31% year-over-year in Q3 2024, raising concerns about profitability. (google.com)
The company's net profit margin declined by 43.45% in Q3 2024, indicating potential operational challenges. (google.com)
Medios AG's cash from operations was negative €6.46 million in Q3 2024, suggesting liquidity issues. (google.com)
Data summarised monthly by Lightyear AI. Last updated on 29 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medios AG stock?
Medios AG (ILM1) has a market cap of €317M as of June 30, 2025.
What is the P/E ratio for Medios AG stock?
The price to earnings (P/E) ratio for Medios AG (ILM1) stock is 20.97 as of June 30, 2025.
Does Medios AG stock pay dividends?
No, Medios AG (ILM1) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Medios AG dividend payment date?
Medios AG (ILM1) stock does not pay dividends to its shareholders.
What is the beta indicator for Medios AG?
Medios AG (ILM1) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.